Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

VVOS
Vivos Therapeutics, Inc. Common Stock
stock NASDAQ

At Close
Aug 4, 2026 3:59:51 PM EDT
0.4600USD+9.786%(+0.0400)31,596,533
0.4000Bid   0.5400Ask   0.1400Spread
Pre-market
Aug 3, 2026 9:16:30 AM EDT
0.4370USD+6.585%(+0.0270)0
After-hours
Aug 4, 2026 4:59:30 PM EDT
0.3500USD-24.095%(-0.1100)16,368,454
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
07:34AM EST  Vivos Therapeutics Files For US Patent On Proprietary New Clinical Protocols After Seeing Further Significant Improvement In Reduction Of Key Sleep Apnea Metric   Benzinga
07:30AM EST  Vivos Therapeutics Files for US Patent on Proprietary New Clinical   GlobeNewswire Inc
05:01AM EST  41 Biggest Movers From Yesterday   Benzinga
Jan 19, 2022
07:32AM EST  Vivos Therapeutics Says Reported 18x Increase In Sleep Apnea Diagnostic Testing By Vivos Dentists Using SleepImage Technology For Three Months Ended Dec. 31   Benzinga
07:30AM EST  Vivos Therapeutics Announces 18X Increase in Sleep Apnea   GlobeNewswire Inc
Dec 14, 2021
07:37AM EST  Vivos Therapeutics' mmRNA Oral Appliance Now Eligible For Medicare Reimbursement   Benzinga
07:30AM EST  Vivos Therapeutics mmRNA Oral   GlobeNewswire Inc
Dec 9, 2021
09:55PM EST  From Benzinga's Global Small Cap Conference: Vivos Therapeutics CEO, R. Kirk Huntsman Says Co's Gross Margins Are Over 70%   Benzinga
09:55PM EST  From Benzinga's Global Small Cap Conference: Vivos Therapeutics CEO, R. Kirk Huntsman Says Co Brings To Market Breakthrough Technology In Both Diagnosis And Treatment Of Mild-To-Moderate OSA   Benzinga
09:55PM EST  From Benzinga's Global Small Cap Conference: Vivos Therapeutics CEO, R. Kirk Huntsman Begins Presenting   Benzinga
09:46PM EST  Vivos Therapeutics Announces Registration With Health Canada To Manufacture And Sell Sleep Disorder, Snoring And Sleep Apnea Appliances To Canadian Dentists   Benzinga
07:30AM EST  Vivos Therapeutics Announces Registration with Health Canada to   GlobeNewswire Inc
Dec 3, 2021
07:30AM EST  Vivos Therapeutics to Participate at the Benzinga Global Small Cap   GlobeNewswire Inc
Nov 15, 2021
05:00PM EST  Vivos Therapeutics Q3 EPS $(0.26) Misses $(0.18) Estimate, Sales $4.50M Inline   Benzinga
04:05PM EST  Vivos Therapeutics Reports Third Quarter 2021 Financial Results   GlobeNewswire Inc
11:07AM EST  Earnings Scheduled For November 15, 2021   Benzinga
07:00AM EST  Vivos Therapeutics to Participate at the Q4 Virtual Investor Summit   GlobeNewswire Inc
Nov 9, 2021
07:30AM EST  Vivos Therapeutics Schedules Third Quarter 2021 Financial Results   GlobeNewswire Inc
Oct 27, 2021
12:17PM EDT  From BZ's Global Small Cap Conference: Vivos Therapeutics CEO, R. Kirk Huntsman Begins Presenting   Benzinga
Oct 22, 2021
07:34AM EDT  Vivos Therapeutics To Participate At Benzinga Global Small Cap Conference Oct. 27   Benzinga
07:30AM EDT  Vivos Therapeutics to Participate at the Benzinga Global Small Cap   GlobeNewswire Inc
Oct 19, 2021
04:01PM EDT  Vivos Therapeutics Announces 2021 Annual Breathing Wellness Conference Presented By The Vivos Institute   Benzinga
04:00PM EDT  Vivos Therapeutics Announces 2021 Annual Breathing Wellness   GlobeNewswire Inc
11:31AM EDT  Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A   PR Newswire
11:31AM EDT  Vivos Therapeutics Reports Strategic Collab With Candid To Deliver Comprehensive Sleep Apnea, Orthodontic Treatment Solution   Benzinga
Oct 18, 2021
07:31AM EDT  Vivos Therapeutics And Candid Announce Strategic Collaboration To Deliver A Comprehensive Sleep Apnea And Orthodontic Treatment Solution   Benzinga
07:30AM EDT  Vivos Therapeutics and Candid Announce Strategic Collaboration to   GlobeNewswire Inc
Oct 13, 2021
01:38PM EDT  Vivos Therapeutics Highlights Clinical Study Showing 'Significant Reduction of Tooth Decay After Treatment with Vivos Guides'   Benzinga
07:30AM EDT  Children in Latest Clinical Study Show Significant Reduction of   GlobeNewswire Inc
Sep 29, 2021
02:22PM EDT  From BZ's Small Cap Healthcare Conference: Vivos Therapeutics CEO, R. Kirk Huntsman Begins Presenting   Benzinga
Sep 23, 2021
07:39AM EDT  Vivos Therapeutics Announces Formation Of New Medical Consortium To Advance Company's Technology For Obstructive Sleep Apnea   Benzinga
07:30AM EDT  Vivos Therapeutics Announces Formation of New Medical Consortium   GlobeNewswire Inc
Sep 22, 2021
07:30AM EDT  Vivos Therapeutics to Participate at the Benzinga Healthcare Small   GlobeNewswire Inc
Sep 8, 2021
07:30AM EDT  Vivos Therapeutics to Participate at the H.C. Wainwright 23rd   GlobeNewswire Inc
Aug 26, 2021
07:34AM EDT  Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment   Benzinga
07:30AM EDT  Vivos Therapeutics and Empower Sleep Launch Cooperative   GlobeNewswire Inc
Aug 25, 2021
06:05AM EDT  Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide   Benzinga
06:05AM EDT  Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates   Benzinga
Aug 24, 2021
12:18PM EDT  Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide   Benzinga
10:13AM EDT  Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates   Benzinga
Aug 23, 2021
02:44PM EDT  Mid-Afternoon Market Update: Dow Gains 270 Points; Vivos Therapeutics Shares Spike Higher   Benzinga
12:14PM EDT  Mid-Day Market Update: Crude Oil Surges 5%; Staffing 360 Solutions Shares Plunge   Benzinga
11:17AM EDT  BioMedNewsBreaks Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance For mmRNA Oral Appliance   Benzinga
10:45AM EDT  Vivos Therapeutics, Inc. (VVOS) shares are rising more than 59 percent on Monday morning trade after FDA granted 510 (K) market clearance for its modified mandibular repositioning nighttime appliance or mmRNA oral device for treating mild to moderate sleep apnea. This is intended to treat mild to moderate obstructive sleep apnea, sleep-disordered breathing, and snoring in adults.   RTTNews
10:06AM EDT  Mid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Trillium Therapeutics   Benzinga
09:28AM EDT  Why Vivos Therapeutics Shares Are Soaring Today   Benzinga
08:53AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Monday, Aug. 23, 2021: PANW, NXTP, VVOS, TOL, CRDL   Benzinga
07:34AM EDT  Vivos Therapeutics Announces The FDA Has Granted 510(k) Market Clearance To Its mmRNA Oral Appliance for Treating Mild to Moderate Sleep Apnea   Benzinga
07:30AM EDT  Part of the Vivos System Treatment, the mmRNA Device Represents a Highly Effective Non-Surgical, Non-Invasive and Non-Pharmaceutical Alternative for Patients Suffering from OSA   GlobeNewswire Inc
Aug 17, 2021
04:10PM EDT  Vivos Therapeutics Announces Detailed Summary Of Study Reporting That One In Four Patients Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment Now Available on Vivos Therapeutics Website   Benzinga
04:05PM EDT  Detailed Summary of Study Reporting that One in Four Patients Show   GlobeNewswire Inc
Aug 13, 2021
01:08PM EDT  Roth Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $10   Benzinga
Aug 12, 2021
05:17PM EDT  Vivos Therapeutics Q2 EPS $(0.19) Misses $(0.18) Estimate, Sales $4.50M Beat $3.60M Estimate   Benzinga
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 9, 2021
04:05PM EDT  Vivos Therapeutics to Participate at the Q3 Virtual Investor Summit   GlobeNewswire Inc
08:00AM EDT  Vivos Therapeutics Schedules Second Quarter   GlobeNewswire Inc
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Jul 29, 2021
08:00AM EDT  Vivos Therapeutics Opens State of the Art International Training   GlobeNewswire Inc
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 23, 2021
07:45AM EDT  The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs   Benzinga
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jul 15, 2021
08:08AM EDT  The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs   Benzinga
Jul 13, 2021
08:11AM EDT  Vivos Therapeutics, Inc. Announces Results From Study Commissioned By Co. Showing 28% Of Patients Treated With Co.'s DNA Appliance Reported No Remaining OSA Symptoms   Benzinga
Jul 7, 2021
08:03AM EDT  Independent Study Shows 97% of Vivos Patients Achieved Their Desired Treatment Outcome   Benzinga
08:00AM EDT  Independent Study Shows 97 Percent of Vivos Patients Achieved   GlobeNewswire Inc
07:41AM EDT  The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend   Benzinga
Jul 1, 2021
08:07AM EDT  The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts   Benzinga
Jun 30, 2021
07:29AM EDT  The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs   Benzinga
Jun 23, 2021
07:35AM EDT  The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway   Benzinga
Jun 4, 2021
09:39AM EDT  The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact   Benzinga
Jun 3, 2021
08:23AM EDT  The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout   Benzinga
May 26, 2021
08:00AM EDT  Vivos Therapeutics Founder & Chief Medical Officer Releases New   GlobeNewswire Inc
07:33AM EDT  The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing   Benzinga
May 20, 2021
08:27AM EDT  The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks   Benzinga
May 18, 2021
10:45AM EDT  Roth Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $11   Benzinga
07:44AM EDT  The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO   Benzinga
May 17, 2021
04:35PM EDT  Vivos Therapeutics Q1 EPS $(0.19) Up From $(0.23) YoY, Sales $3.40M Up From $3.20M YoY   Benzinga
04:05PM EDT  Vivos Therapeutics Reports First Quarter 2021 Financial Results   GlobeNewswire Inc
May 14, 2021
03:03PM EDT  The Promise Of Longevity Science: 3 Small-Cap Companies With Anti-Aging Products   Benzinga
06:48AM EDT  Schedule For Benzinga's Global Small Cap Conference Friday, May 14, 2021   Benzinga
May 13, 2021
08:00AM EDT  Vivos Therapeutics Schedules First Quarter   GlobeNewswire Inc
May 11, 2021
04:29PM EDT  Vivos Therapeutics Announces Closing of Follow-On Offering and   GlobeNewswire Inc
Apr 15, 2021
10:54AM EDT  Vivos Therapeutics Leads the Battle Against Obstructive Sleep Apnea (OSA)   Benzinga
Apr 14, 2021
09:15AM EDT  Vivos Therapeutics Announces Integrative Cardiologist Dr. Mimi   GlobeNewswire Inc
Apr 12, 2021
08:00AM EDT  Vivos Therapeutics to Participate at the Emerging Growth Conference   GlobeNewswire Inc
06:00AM EDT  EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies announces the Schedule of the 5th Emerging Growth Conference.   GlobeNewswire Inc
Mar 30, 2021
08:05AM EDT  Vivos Therapeutics Says Launching MyoCorrect Orofacial Myofunctional Therapy Service   Benzinga
08:00AM EDT  Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional   GlobeNewswire Inc
Mar 26, 2021
04:39PM EDT  Highlights From Day 2 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 25, 2021
04:08PM EDT  Vivos Therapeutics Q4 Sales $3.30M Up From $3.10M YoY   Benzinga
04:05PM EDT  Vivos Therapeutics Reports Fourth Quarter and Full Year   GlobeNewswire Inc
12:00PM EDT  From BZ Biotech Conference: Vivos Therapeutics Chairman, CEO R. Kirk Huntsman Concludes Segment   Benzinga
11:57AM EDT  From BZ Biotech Conference: Vivos Therapeutics Chairman, CEO R. Kirk Huntsman Says 'Think Everyone Will Be Smiling' After Co. Releases Earnings Results Tonight   Benzinga
11:54AM EDT  From BZ Biotech Conference: Vivos Therapeutics Chairman, CEO R. Kirk Huntsman Says Co. Has Treated 15,000 Patients, Notes 'Great Margins'   Benzinga
11:53AM EDT  From BZ Biotech Conference: Vivos Therapeutics Chairman, CEO R. Kirk Huntsman Says Co. Treats Patients For 12-24 Months, Compared To Other Solutions Lasting For Life   Benzinga
11:52AM EDT  From BZ Biotech Conference: Vivos Therapeutics Chairman, CEO R. Kirk Huntsman Says Co. Wants To Find Patients With Accurate Diagnosis, Offer Treatment   Benzinga
11:48AM EDT  From BZ Biotech Conference: Vivos Therapeutics Chairman, CEO R. Kirk Huntsman Highlights Co.'s Opportunities To Mitigate Obstructive Sleep Apnea; Says 80% Of Patients Don't Know Diagnosis, Co. Offers VivoScore Home Sleep Test   Benzinga
Mar 22, 2021
04:05PM EDT  Vivos Therapeutics to Participate at the Benzinga Biotech Small   GlobeNewswire Inc
Mar 18, 2021
08:00AM EDT  Vivos Therapeutics Schedules Fourth Quarter and Full Year 2020   GlobeNewswire Inc
Mar 11, 2021
07:55AM EST  Vivos management to present at 1:30 pm Eastern Time on March 23, 2021   GlobeNewswire Inc
Mar 8, 2021
08:46AM EST  Vivos Therapeutics Announces the Opening of the First   GlobeNewswire Inc
Mar 1, 2021
08:00AM EST  Vivos Therapeutics to Participate in the Virtual 33rd Annual ROTH   GlobeNewswire Inc
Feb 24, 2021
08:32AM EST  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Feb. 24, 2021: JNJ, TGT, MAT, VCVC, VVOS   Benzinga
Feb 23, 2021
01:56PM EST  EXCLUSIVE: Vivos Therapeutics CEO Notes Co. Is Not Profitable But 'We Have A Path To Profitability That Is Much Shorter...Than Co.'s Coming Out Like Us'   Benzinga
01:55PM EST  EXCLUSIVE: Vivos Therapeutics CEO Notes Co. Is Not Profitable But 'We Have A Path To Profitability That Is Much Shorter...'   Benzinga
01:53PM EST  EXCLUSIVE: Vivos Therapeutics CEO Notes 'Shark Tank's Kevin Harrington Is In An Investor In Co.   Benzinga
01:53PM EST  EXCLUSIVE: Vivos Therapeutics CEO, When Asked About Other FDA Items Coming Down Pipeline Says 'Yes There Are,' But 'None That Are Required' to Fully Realize Commercial Value Of Our' Sleep Apnea Product   Benzinga
01:49PM EST  EXCLUSIVE: Vivos Therapeutics CEO, When Asked About Co.'s 510(k) Class II Application For Its mRNA Oral Appliance, Says Should Know More Details About Application 'Very Shortly'   Benzinga
01:48PM EST  EXCLUSIVE: Vivos Therapeutics CEO Notes Every Patient Receives A Custom Sleep Apnea Appliance, Allows Effective Targeting Of Improvement For Specific Patient's Sleep Apnea Issues   Benzinga
01:46PM EST  EXCLUSIVE: Vivos Therapeutics CEO Notes Co. Recently Treated A Big Celebrity's Sleep Apnea: Donny Osmond, Right Before He Retired   Benzinga
01:45PM EST  EXCLUSIVE: Vivos Therapeutics Chief Strategy Officer Notes Co. Has Partnered With NFL Players Association In Past, But Notes Partnership With Physicians/Dentists In Next Few Weeks Will Create 'A Lot Of Momentum'   Benzinga
01:44PM EST  EXCLUSIVE: Vivos Therapeutics CEO Says 'Visibility Is A Big Challenge' For Co. But 'Visibility Is Coming,' Notes Co. Is Making Videos Highlighting Collaboration Among Dentists And Physicians Related To Sleep Apnea   Benzinga
01:43PM EST  EXCLUSIVE: Vivos Therapeutics CEO Says Insurance Will Cover Up To ~70% Of Cost For Co.'s Sleep Apnea Appliance   Benzinga
01:42PM EST  EXCLUSIVE: Vivos Therapeutics CEO Says Co.'s Sales Model Follows Same As Another Player In Dental Space, Align Technology   Benzinga
01:41PM EST  EXCLUSIVE: Vivos Therapeutics CEO Says, When Co. Reports Upcoming Q4 Earnings, Will Not Show 3x Growth It Had Previously Shown, But Notes Dentist Offices Had Been Shutdown For A Long Time Amid COVID, Says 'Will Show Good Growth'   Benzinga
01:40PM EST  EXCLUSIVE: Vivos Therapeutics CEO Kirk Huntsman, Highlighting Competitor Device From Inspire Medical (Ticker 'INSP') As A Surgically-Placed Sleep Apnea Treatment, Notes Co.'s Vivos Product Is Non Surgical   Benzinga
01:35PM EST  EXCLUSIVE: Vivos Therapeutics Chief Strategy Officer Ed Loew Also Interviewing On Benzinga's ZingerNation Power Hour YouTube Show   Benzinga
01:33PM EST  EXCLUSIVE: Vivos Therapeutics CEO Kirk Huntsman Discussing Co.'s Vivos Sleep Apnea Appliance On Benzinga's ZingerNation Power Hour YouTube Show   Benzinga
01:29PM EST  EXCLUSIVE: Vivos Therapeutics Shares Tick Higher Just Ahead Of Co. CEO, Kirk Huntsman, Interview On Benzinga's ZingerNation Power Hour YouTube Show   Benzinga
Feb 16, 2021
08:10AM EST  Vivos Therapeutics Launches VivoScore Diagnostic Technology For Home Sleep Apnea Testing In Children And Adults   Benzinga
08:00AM EST  Vivos Therapeutics, Inc. (the Company) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA), today announced the launch of VivoScoreTM, powered by SleepImage.   GlobeNewswire Inc
Feb 2, 2021
08:01AM EST  Vivos Therapeutics Submits FDA 510(k) Application   GlobeNewswire Inc
08:01AM EST  Vivos Therapeutics Submits FDA 510(k) Application For The Vivos mmRNA Oral Appliance   Benzinga
Jan 29, 2021
08:00AM EST  Vivos Therapeutics Forms Clinical Advisory Board to Drive Further   GlobeNewswire Inc
Jan 11, 2021
12:27PM EST  Craig-Hallum Initiates Coverage On Vivos Therapeutics with Buy Rating, Announces Price Target of $12   Benzinga
Jan 6, 2021
08:04AM EST  Vivos Therapeutics Launches AireO2 Patient Management Technology To Treat Patents With Obstructive Sleep Apnea   Benzinga
08:00AM EST  Vivos Therapeutics Launches AireO2 Patient Management Technology   GlobeNewswire Inc
Jan 5, 2021
01:58PM EST  Vivos Therapeutics shares were trading higher after Roth Capital initiated coverage on the stock with a Buy rating and announced a $12 price target.   Benzinga
10:11AM EST  Benzinga's Top Upgrades, Downgrades For January 5, 2021   Benzinga
08:39AM EST  The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data   Benzinga
07:40AM EST  Roth Capital Initiates Coverage On Vivos Therapeutics with Buy Rating, Announces Price Target of $12   Benzinga
Dec 30, 2020
08:16AM EST  The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data   Benzinga
Dec 28, 2020
11:26AM EST  Insider Buys Vivos Therapeutics Shares   Benzinga
Dec 17, 2020
10:07AM EST  Shares of Vivos Therapeutics, Inc. (VVOS) are currently gaining over 35% despite no stock-related news to drive the shares.   RTTNews
08:10AM EST  The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut   Benzinga
Dec 16, 2020
07:15AM EST  The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal   Benzinga
Dec 15, 2020
05:18PM EST  Vivos Therapeutics Announces Closing of Initial Public Offering   GlobeNewswire Inc
Dec 14, 2020
11:15AM EST  Insider Buys Vivos Therapeutics Stock   Benzinga
Dec 11, 2020
10:01AM EST  Vivos Therapeutics Shares Open For Trade At $7.07; IPO Priced At $6/Share   Benzinga
09:46AM EST  IPOs for today: VVOS, ABCL, EDTXU, GLAQU, TVACU, SNRHU, NBTX, ROCCU, GHVIU, CERT, FDMT, MOTVU, DWINU, CBAHU, PCPCU   Benzinga
09:31AM EST  Vivos Therapeutics Shares Will Open For Quote At 9:50 a.m. EST, Expected To Open For Trade After 10 a.m. EST; IPO Priced At $6/Share   Benzinga
Dec 10, 2020
09:43PM EST  Vivos Therapeutics Announces Pricing of $21M Initial Public Offering   GlobeNewswire Inc
Dec 6, 2020
10:50AM EST  IPO Outlook For The Week: Airbnb, DoorDash Lead Highly Anticipated Week   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC